Madison, WI
Madison Concourse Hotel
August 27-28,  2026
9.75 CE/CME/CPE and ABPath MOC 

Advancing Precision Cancer Care Through Multidisciplinary Collaboration

Madison, WI
August 27-28, 2026

Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Madison

Advancing science through collaboration and shared purpose

Madison is home to leading research institutions and clinical innovators advancing cancer discovery, molecular medicine, and precision oncology across the Midwest. The Advancing Precision Oncology and Advancing Pathology Education meeting will bring together pathologists, oncologists, translational researchers, and healthcare professionals for a multidisciplinary program focused on connecting diagnostic insight with real-world therapeutic decision-making.

The program will be co-chaired by Razelle Kurzrock, MD, FACP, Associate Director of Clinical Research at the Medical College of Wisconsin Cancer Center, and Jeremy Kratz, MD, Assistant Professor in the Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health, physician-scientist at the UW Carbone Cancer Center, and investigator with UW’s Center for Precision Medicine.

Dr. Kurzrock is a globally recognized leader in precision oncology, biomarker-driven clinical trials, rare cancers research, and experimental therapeutics. She has led more than 100 clinical trials and has been instrumental in advancing personalized treatment strategies that match patients to therapies based on the molecular profile of their disease.

Dr. Kratz’s clinical and research interests focus on hepatobiliary and pancreatic cancers, with an emphasis on patient-derived cancer models, molecular profiling, targeted therapeutics, and mechanisms of treatment resistance. Through his work with the Center for Precision Medicine and UW Carbone Cancer Center, he helps advance translational strategies that connect molecular insights with precision cancer care.

Through dialogue across pathology, oncology, and translational science, this meeting will highlight emerging discoveries and practical strategies that support precision oncology in everyday clinical practice. Attendees will gain actionable insights and collaborative perspectives to help advance cancer care throughout the region.

Continuing education credits, including CME/CE and MOC, are planned for this activity.

Agenda

EVENT PARTNERS

August 27, 2026
7:45 AMRegistration & Check-in
8:25 AMWelcome and Introductions Razelle Kurzrock, MD, FACP, Medical College of Wisconsin; Jeremy Kratz, MD, University of Wisconsin
8:30 AMLung Cancer  Dhruv Bansal, MD, Endeavor Health
8:55 AMMCW Update on Precision Targeting of SCLC Hui-Zi Chen, MD, PhD, Medical College of Wisconsin
9:20 AMPathology Perspectives in Lung Cancer Jefree Schulte, MD, University of Wisconsin
9:45 AMTargeted Therapeutics in Lung Cancer Panel Dhruv Bansal, MD; Hui Zi Chen, MD; Leah Wells, MD
10:00 AMExhibits/Breakfast
10:30AMNon-CME Session Martin F. Dietrich, MD, PhD, FACP, University of Central Florida College of Medicine
10:50 AMExhibits/Networking
11:20 AMImmunotherapy of Rare Cancers: the NCI SWOG DART Experience
11:50 AMPrecision Targeting in Lung Cancer Leah Wells, MD, University of Wisconsin
12:20 PMBispecific Cancer Therapies – Hitting the Target in Small Cell Lung Cancer
12:50 PMColorectal Cancer: Biomarkers & Methodologies Stanley Hamilton, MD, FCAP, AGAF, University of Texas MD Anderson Cancer Center
1:20 PMColorectal Cancer Updates
1:50 PMExhibits/Lunch
2:20 PMNon-CME Session
3:00 PMExhibits/Break
3:30 PMPanel Discussion: Precision Oncology in the Community Setting Adedayo Onitilo,MD,PhD,MSCR,FACP, Marshfield Clinic; Matthias M. Weiss, MD, ThedaCare Regional Cancer Center
4:15 PMPrecision Oncology Impact on Patient Partnerships Toby Campbell, MD, University of Wisconsin
4:45 PMPatient Narrative
5:15 PMPanel Discussion: Translating Precision Oncology Advances into Practice Razelle Kurzrock, MD, FACP, Medical College of Wisconsin; Jeremy Kratz, MD, University of Wisconsin
5:45 PMAdjourn
  • Integrate evidence-based advances from both pathology and oncology to enhance biomarker testing, diagnosis, and treatment planning for solid tumors and hematologic malignancies.

  • Apply multidisciplinary insights and new clinical data to improve therapeutic decision-making and patient outcomes across diverse practice settings.

August 28, 2026
9:00 AMRegistration & Check-in
9:25 AMWelcome & Day One Wrap-Up  Razelle Kurzrock, MD, FACP, Medical College of Wisconsin; Jeremy Kratz, MD, University of Wisconsin
9:30 AMPrecision Targeting of Rare Cancers Based on Multiple Omics Razelle Kurzrock, MD, Medical College of Wisconsin
10:00 AMChronic Lymphocytic Leukemia 
10:30 AMBreakfast/Exhibits
10:50 AMNon-CME Session
11:10 AMExhibits/Networking
11:40 PMBreast Cancer Debate: Tissue vs. ctDNA – When, Where, Why, How?  Dustin Deming, MD, University of Wisconsin
12:10 PMReceptor Tyrosine Kinase Targeting in Breast Cancer Kristopher Lofgren, PhD, Gundersen Health System
12:40 PMEmerging Precision Targets in Hematological Malignancies
1:10 PMNext-Generation Genomic Tools Joel Swenson, MD, University of Wisconsin; Sean McIlwain, PhD, University of Wisconsin
1:40 PMPanel Discussion: Advancing Precision Oncology Across Tumor Types Razelle Kurzrock, MD. FACP, Medical College of Wisconsin; Jeremy Kratz, MD, University of Wisconsin
2:00 PMAdjourn

Speakers

THE LOCATION

Madison Concourse Hotel
1 W Dayton Street
Madison, WI  53703

REGISTRATION OPEN

SPONSOR

Interested in sponsoring the event? Email Gary King by using the link below!

Sponsor